Intelligent Bio Solutions ROE 2020-2025 | INBS
Current and historical return on equity (ROE) values for Intelligent Bio Solutions (INBS) over the last 10 years. Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
| Intelligent Bio Solutions ROE - Return on Equity Historical Data | |||
|---|---|---|---|
| Date | TTM Net Income | Shareholder's Equity | Return on Equity |
| 2025-03-31 | $-0.01B | $0.01B | -191.30% |
| 2024-12-31 | $-0.01B | $0.00B | -151.72% |
| 2024-09-30 | $-0.01B | $0.01B | -157.14% |
| 2024-06-30 | $-0.01B | $0.01B | -173.91% |
| 2024-03-31 | $-0.01B | $0.01B | -210.53% |
| 2023-12-31 | $-0.01B | $0.00B | -371.43% |
| 2023-09-30 | $-0.01B | $0.00B | -209.52% |
| 2023-06-30 | $-0.01B | $0.00B | -160.00% |
| 2023-03-31 | $-0.01B | $0.01B | -128.57% |
| 2022-12-31 | $0.00B | $0.01B | -51.61% |
| 2022-09-30 | $-0.01B | $0.01B | -90.32% |
| 2022-06-30 | $-0.01B | $0.01B | -70.00% |
| 2022-03-31 | $-0.01B | $0.01B | -50.00% |
| 2021-12-31 | $-0.01B | $0.01B | -58.18% |
| 2021-09-30 | $-0.01B | $0.01B | -43.75% |
| 2021-06-30 | $-0.01B | $0.02B | -56.00% |
| 2020-12-31 | $0.00B | $0.02B | -63.16% |
| 2020-09-30 | $0.00B | $0.00B | 0.00% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $0.011B | $0.003B |
| Intelligent Bio Solutions Inc. is a life sciences company developing non-invasive, real-time monitoring and diagnostic tests for patients and their primary health practitioners. Intelligent Bio Solutions Inc., formerly known as GBS Inc., is based in NEW YORK. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Danaher (DHR) | United States | $143.611B | 26.63 |
| CVS Health (CVS) | United States | $83.126B | 10.34 |
| Elevance Health (ELV) | United States | $66.200B | 8.90 |
| Cencora (COR) | United States | $55.265B | 18.41 |
| DiDi Global (DIDIY) | China | $26.074B | 27.70 |
| Labcorp Holdings (LH) | United States | $22.092B | 17.56 |
| Natera (NTRA) | United States | $20.748B | 0.00 |
| BioMerieux (BMXMF) | France | $17.652B | 0.00 |
| EUROFINS SCIENT (ERFSF) | Luxembourg | $14.860B | 0.00 |
| CochLear (CHEOY) | Australia | $13.234B | 0.00 |
| ICON (ICLR) | Ireland | $12.795B | 12.31 |
| Solventum (SOLV) | United States | $12.697B | 13.13 |
| Medpace Holdings (MEDP) | United States | $12.202B | 32.29 |
| Viatris (VTRS) | United States | $11.385B | 4.02 |
| Revvity (RVTY) | United States | $10.080B | 17.76 |
| Sonic Healthcare (SKHHY) | Australia | $8.961B | 0.00 |
| HealthEquity (HQY) | United States | $8.047B | 35.25 |
| Avantor (AVTR) | United States | $7.840B | 11.50 |
| Caris Life Sciences,�Inc (CAI) | United States | $7.568B | 0.00 |
| Charles River Laboratories (CRL) | United States | $7.320B | 13.89 |
| Bausch + Lomb (BLCO) | Canada | $4.828B | 32.48 |
| Sotera Health (SHC) | United States | $3.965B | 22.17 |
| Amplifon S.p.A (AMFPF) | Italy | $3.937B | 21.82 |
| BrightSpring Health Services (BTSG) | United States | $3.681B | 28.08 |
| Surgery Partners (SGRY) | United States | $3.031B | 38.13 |
| GeneDx Holdings (WGS) | United States | $3.000B | 69.16 |
| Alignment Healthcare (ALHC) | United States | $2.873B | 0.00 |
| Concentras Parent (CON) | United States | $2.771B | 17.58 |
| Organon (OGN) | United States | $2.397B | 2.61 |
| Progyny (PGNY) | United States | $1.959B | 41.55 |
| Premier (PINC) | United States | $1.921B | 14.58 |
| Ardent Health (ARDT) | United States | $1.702B | 6.57 |
| PACS (PACS) | United States | $1.698B | 0.00 |
| Pediatrix Medical (MD) | United States | $1.248B | 8.33 |
| GoodRx Holdings (GDRX) | United States | $1.239B | 20.41 |
| Teladoc Health (TDOC) | United States | $1.230B | 0.00 |
| Establishment Labs Holdings (ESTA) | $1.006B | 0.00 | |
| Ryman Healthcare (RYHTY) | New Zealand | $0.970B | 0.00 |
| Embecta (EMBC) | United States | $0.718B | 4.21 |
| AMN Healthcare Services Inc (AMN) | United States | $0.660B | 8.17 |
| CareDx (CDNA) | United States | $0.637B | 11.74 |
| Performant Healthcare (PHLT) | United States | $0.597B | 0.00 |
| QDM (QDMI) | Hong Kong, SAR China | $0.586B | 201.00 |
| So-Young (SY) | China | $0.506B | 0.00 |
| Omada Health (OMDA) | $0.490B | 0.00 | |
| Nutex Health (NUTX) | United States | $0.488B | 7.39 |
| Auna S.A (AUNA) | Luxembourg | $0.460B | 10.37 |
| Sonida Senior Living (SNDA) | United States | $0.460B | 0.00 |
| SBC Medicals (SBC) | United States | $0.456B | 0.00 |
| InnovAge Holding (INNV) | United States | $0.447B | 0.00 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.421B | 0.00 |
| Enhabit (EHAB) | United States | $0.386B | 25.40 |
| Oncology Institute (TOI) | United States | $0.382B | 0.00 |
| Agilon Health (AGL) | United States | $0.362B | 0.00 |
| LifeMD (LFMD) | United States | $0.323B | 0.00 |
| Beauty Health (SKIN) | United States | $0.238B | 0.00 |
| DocGo (DCGO) | United States | $0.160B | 0.00 |
| Ascend Wellness Holdings (AAWH) | United States | $0.106B | 0.00 |
| Sera Prognostics (SERA) | United States | $0.093B | 0.00 |
| KindlyMD (NAKA) | United States | $0.073B | 0.00 |
| NeueHealth (NEUE) | United States | $0.060B | 0.00 |
| Biodesix (BDSX) | United States | $0.059B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.048B | 0.00 |
| Basel Medical Group (BMGL) | Singapore | $0.038B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.037B | 0.00 |
| ModivCare (MODV) | United States | $0.035B | 0.00 |
| OSR Holdings (OSRH) | United States | $0.012B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.010B | 0.00 | |
| SeaStar Medical Holding (ICU) | United States | $0.009B | 0.00 |
| Co-Diagnostics (CODX) | United States | $0.009B | 0.00 |
| XWELL (XWEL) | United States | $0.007B | 0.00 |
| Pheton Holdings (PTHL) | China | $0.006B | 0.00 |
| Aclarion (ACON) | United States | $0.004B | 0.00 |
| ISpecimen (ISPC) | United States | $0.003B | 0.00 |
| NewGenIvf Group (NIVF) | Thailand | $0.002B | 0.00 |
| INVO Fertility (IVF) | United States | $0.001B | 0.00 |
| Cano Health (CANOQ) | United States | $0.000B | 0.00 |